Our Team

Board of Directors


Louis M. Bowen

Chairman and Chief Financial Officer

Louis Bowen, MBA, is the Executive Chairman and Chief Financial Officer of PGTx Limited.  He also currently serves as the Executive Chairman and CFO of Pacific GeneTech Limited, an animal health biotech company he co-founded in 2009.


He also serves as the Chairman and CEO of Asia Capital Management Limited, a private investment banking company based in Hong Kong that he founded in 1994. Louis started his career with Citigroup in New York, before relocating to Hong Kong to establish the Citigroup corporate finance activities in Asia. Louis has overseen many investments and acquisitions in Asia across a range of industries including pharmaceuticals, primary care services, and medical diagnostics.

Louis has served on the boards of a number of companies during his professional career and currently serves on the Advisory Council of the Hong Kong University of Science and Technology Business School, The Dean’s Executive Advisory Board of the Walton School of Business at the University of Arkansas, the Board of Governors of the Wharton Alumni Association of Hong Kong and the Board of Advisors of the Arkansas World Trade Center.


Louis holds an MBA in Finance from the Wharton School and has a BA in Economics from the University of Arkansas.

Tim Collard PGT.jpg

Tim Collard

Chief Executive Officer

Tim Collard is the Chief Executive Officer of PGTx Limited and is responsible for the overall management and operations of the company. Tim has more than 40 years’ experience in the global pharmaceutical and biotechnology industries. In 1975 he started his career working with Connaught Laboratories supplying human vaccines to the Hong Kong government and was also involved in development of Connaught’s veterinary vaccines. In 1977 he was recruited by Califas, a China-based consultancy, where he negotiated the first Sino-US joint manufacturing contract in the Chinese healthcare industry and preliminary joint venture agreements between Squibb and the Chinese government. 

In 1980 Tim joined Solvay as Far East Director for Solvay’s Biochem Products division, a joint venture with the Pasteur Institute, which developed human and agricultural biologicals. In 1987 he became General Manager, Far East, of British biopharmaceuticals company Porton International where he established marketing, distribution, and local R&D in Asia for human vaccines and biopharmaceuticals, including Porton’s botulinum toxin for treatment of neurological diseases. 

In 1993, Tim served as Vice President of Lotus Healthcare Corporation, a manufacturer of oral controlled-release morphine and dihydrocodeine in China. He was responsible for business development, sourcing of Chinese pharmaceutical raw materials, and all in-licensing and technology transfer. In 1997, he established Phoenix Lifesciences to provide transactional consultancy services to the biotechnology sector in Greater China and Southeast Asia. In this consulting capacity, Tim negotiated a “first mover” supply agreements for bulk antibiotics between a Chinese producer and British pharmaceutical companies. Tim continued to work on a variety of projects with local and multinational companies including AstraZeneca, Authentix, Aventis, bioMérieux, Proctor & Gamble, SciClone, and Xenova.


Tim holds a BS in biology from Bristol University in the United Kingdom.

James Brown.jpg

James Brown

Member, Board of Directors

James Brown, CPA, JD, is Managing Director of AVG Ventures, an investment firm specialising in early to mid-stage technology companies. Prior to joining AVG Ventures, Mr Brown was an independent investor and Member of the Board for numerous companies. Before that, he served in several executive operating roles in public and private technology companies, with responsibilities ranging from finance and legal to operations and strategy.

Previously, Mr Brown was Executive Vice President and General Manager of OpenTV, Inc., a technology and media company which he helped to take public.He was also responsible for founding and managing the company’s applications business unit until its sale to Liberty Media.

Mr Brown started his career practicing law, specialising in corporate finance and technology transactions. He served as a Partner at McDermott, Will & Emery in Menlo Park and Pillsbury Madison & Sutro in San Francisco.

Mr Brown holds a Bachelors of Science in Accounting from Weber State University and a Juris Doctorate from Brigham Young University Law School where he was Executive Editor of the Law Review and graduated magna cum laude. He is a Certified Public Accountant (inactive) and an active member of the California Bar Association.